Tesamorelin + Ipamorelin: a gh-axis blend of Tesamorelin + Ipamorelin. Two GH-axis levers in one stack.
1.4-2 mg Tesamorelin + 200 mcg Ipamorelin total daily (mostly tesamorelin by mass), sub-q.
Once daily before bed, 12+ week cycle
12 mg total (pre-mixed)
1700 mcg per injection
What's in it
Why they're paired
Two GH-axis levers in one stack. Tesamorelin is FDA-approved for HIV-associated lipodystrophy and specifically targets visceral fat. Ipamorelin amplifies the GH pulse with cleaner side effects than Hexarelin or GHRP-2. The combination is community-popular for users who want both the visceral-fat-targeting effect and the cleaner pulse on top.
Who runs it
Users with elevated visceral fat targeting body comp via the GH axis. Older adults running anti-aging protocols who want a stronger GH-axis lift than CJC+Ipa alone.
Blend vs running singles
Tesamorelin works on its own and is FDA-approved on its own. Adding Ipamorelin is an off-label community pattern, not a clinical protocol. Singles give you the option to step Tesamorelin alone first and verify response before adding the secretagogue layer.
Work out exact units to draw for this blend.
What every test on a Certificate of Analysis means.